Lido Advisors, LLC Tyme Technologies, Inc. Transaction History

Lido Advisors, LLC

$20.3 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 15, 2022	SELL	$0.6 - $1.04 $14,770 - $25,601	-24,617 Closed	0 $0
Q3 2021 Feb 15, 2022	BUY	$0.99 - $1.38 $7,504 - $10,460	7,580 Added 44.49%	24,617 $25,000
Q3 2021 Nov 12, 2021	SELL	$0.99 - $1.38 $7,504 - $10,460	-7,580 Reduced 30.79%	17,037 $25,000
Q1 2021 May 13, 2021	BUY	$1.34 - $3.53 $4,124 - $10,865	3,078 Added 14.29%	24,617 $44,000
Q2 2020 Aug 12, 2020	BUY	$0.97 - $1.7 $20,892 - $36,616	21,539 New	21,539 $29,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.